Safemed Formulation Private Limited
About Safemed Formulation Private Limited
Data last updated:
Safemed Formulation Private Limited was a private limited company based in Dehradun, Uttarakhand, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the support services segment of the services sector. It was incorporated on 30 August 2010.
The company was registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U85191UR2010PTC033278.
The company had an authorised share capital of ₹3 Lakh and a paid-up capital of ₹2.6 Lakh. It was led by directors including Abhinav Dixit and Vijay Kumar Bijole.
Its last annual general meeting (AGM) was held on 30 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at N.P.Chauk Shastradhara Road, Dehradun, Uttarakhand, India – 248001.
As per the financials filed for FY 2017, the company reported a revenue of ₹1.21 Lakh, a growth of 7% compared to the previous year. For the same year it recorded a net loss of ₹1,873 (net margin -1.5%) and EBITDA of -₹1,018 (EBITDA margin -0.8%).
Company details
Contact details
Safemed Formulation Private Limited's registered office is in Dehradun, Uttarakhand. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressN.P.Chauk Shastradhara Road, Dehradun, Uttarakhand, India – 248001
- IndustryService, Other Support Services
To see the full contact details of Safemed Formulation Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Safemed Formulation is support service to organizations. In detail, this covers other support services to organizations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations |
To see the full business activity and turnover split of Safemed Formulation Private Limited, buy the company report.
Financials of Safemed Formulation Private Limited
FY 2017 filings availableSafemed Formulation Private Limited reported revenue of ₹1.21 Lakh (up 7% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue rose 7% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹1.21 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹1,018 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹1,873 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -0.8% | ||
| Net Profit Margin | -1.5% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Safemed Formulation Private Limited, buy the company report.
Board of directors of Safemed Formulation Private Limited
Safemed Formulation has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abhinav Dixit | Director | 30 Aug 2010 | 16 Years 1 Months | As last reported |
| Vijay Kumar Bijole | Director | 30 Aug 2010 | 16 Years 1 Months | As last reported |
| Urmila Gupta Also directs: Aapoorti Warehouse and Logistics Private Limited | Director | 30 Aug 2010 | 16 Years 1 Months | As last reported |
Peer comparison
Safemed Formulation Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other support services to organizations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Conquer Advisory Services Private Limited | ₹1.22 Lakh (FY 2019) | 388.0% | Hubli, Karnataka, India | |||
| Pakkaprofile Psychometrics Private Limited | ₹1.22 Lakh (FY 2024) | -97.0% | Bangalore, Karnataka, India | |||
| Grintex Innovation Labs Private Limited | ₹1.22 Lakh (FY 2025) | -51.0% | Gurgaon, Haryana, India | |||
| Acrosscity Advertising Private Limited | ₹1.22 Lakh (FY 2021) | Ghaziabad, Uttar Pradesh, India | ||||
| Sunaina Infrastructure Private Limited | ₹1.22 Lakh (FY 2025) | -84.0% | Patna, Bihar, India | |||
| Safemed Formulation Private Limitedthis company | ₹1.21 Lakh (FY 2017) | -₹1,873 | -1.5% | 7.0% | Dehradun, Uttarakhand, India | |
| Nellai Consulting Private Limited | ₹1.21 Lakh (FY 2025) | 485.0% | Perumalpuram, Tamil Nadu, India | |||
| Ogorooms Stays Private Limited | ₹1.21 Lakh (FY 2024) | 146.0% | Jaipur, Rajasthan, India | |||
| Unoffice Business Services Private Limited | ₹1.21 Lakh (FY 2021) | Delhi, India | ||||
| Avsr Kendra Private Limited | ₹1.21 Lakh (FY 2025) | -44.0% | Delhi, India | |||
| Cosfin Capital Securities Private Limited | ₹1.21 Lakh (FY 2021) | Patna, Bihar, India |
To see the full peer comparison of Safemed Formulation Private Limited, buy the company report.
Auditor
Safemed Formulation Private Limited is audited by GUPTA HARI OM AND ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GUPTA HARI OM AND ASSOCIATES | FY 2017 | 013683C |
Shareholding
The shareholding of Safemed Formulation Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Safemed Formulation Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Safemed Formulation Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Safemed Formulation Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Safemed Formulation Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Safemed Formulation Private Limited has 3 board changes on record since 2010: 3 appointments. The latest: Abhinav Dixit was appointed as Director on 30 Aug 2010.
Frequently asked questions
Safemed Formulation has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Safemed Formulation was a private limited company based in Dehradun, Uttarakhand, India. The company worked in other support services, within the service industry. It was incorporated on 30 August 2010 and is registered under CIN U85191UR2010PTC033278. The company has been struck off by the Registrar of Companies and is no longer operational.
Safemed Formulation had 3 directors:
- Abhinav Dixit - Director
- Vijay Kumar Bijole - Director
- Urmila Gupta - Director
The CIN (Corporate Identification Number) of Safemed Formulation is U85191UR2010PTC033278. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Safemed Formulation is at N.P.Chauk Shastradhara Road, Dehradun, Uttarakhand, India – 248001.
Safemed Formulation was incorporated on 30 August 2010. It is registered with the Registrar of Companies, Uttarakhand.
The latest financial statements of Safemed Formulation on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 30 September 2017. Year-wise statements from 2015 are in the company report.
Safemed Formulation operated in the service industry, in the other support services segment. It worked in this industry before it was struck off.
The peers of Safemed Formulation by revenue are Conquer Advisory Services Private Limited, Pakkaprofile Psychometrics Private Limited, Grintex Innovation Labs Private Limited, Acrosscity Advertising Private Limited, Sunaina Infrastructure Private Limited and 5 more, all in the same principal business activity (other support services to organizations).
Abhinav Dixit was appointed as Director on 30 Aug 2010. Urmila Gupta was appointed as Director on 30 Aug 2010. Vijay Kumar Bijole was appointed as Director on 30 Aug 2010.
The compliance status of Safemed Formulation is active non-compliant as of 18 August 2026.